A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2011
08/25/2011	US20110207679 Methods of treatment using il-16 antagonist peptides
08/25/2011	US20110206765 Non-Typeable Haemophilus Influenzae Vaccines and Their Uses
08/25/2011	US20110206760 Angiopoietin derived peptides
08/25/2011	US20110206758 Vaccine Compositions Comprising a Saponin Adjuvant
08/25/2011	US20110206757 Novel glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof
08/25/2011	US20110206756 Dithiocarbamate metal chelates and methods of making and using thereof
08/25/2011	US20110206755 Methods and products for manipulating uncoupling protein expression
08/25/2011	US20110206742 Immunotherapeutic compositions for the treatment of alzheimer's disease
08/25/2011	US20110206740 Cell Membrane Engineering
08/25/2011	US20110206736 Cancer Vaccines Against Mucosal Antigens and Methods of Making and Using the Same
08/25/2011	US20110206735 Tumorigenic CancerStemCells, Methods of Isolating and Using the Same
08/25/2011	US20110206734 Hybrid scfa-hydroxyl-derivatized monosaccharides, methods of synthesis, and methods of treating disorders
08/25/2011	US20110206733 Immunizing Compositions and Methods of Use
08/25/2011	US20110206732 Albumin for treating cancer and a pharmaceutical composition comprising the combination of an anti-neoplastic agent and albumin
08/25/2011	US20110206731 Botulinum toxin therapy for skin disorders
08/25/2011	US20110206730 Dengue Chimeric Viruses
08/25/2011	US20110206729 Mucosal vaccine using cationic nanogel
08/25/2011	US20110206728 Dna vaccines, uses for unprocessed rolling circle amplification product and methods for making the same
08/25/2011	US20110206727 Multivalent Vaccines Based on Papaya Mosaic Virus and Uses Thereof
08/25/2011	US20110206726 Combination vaccine with acellular pertussis
08/25/2011	US20110206725 Method for purifying protein complexes
08/25/2011	US20110206724 Hepatitis virus core proteins as vaccine platforms and methods of use thereof
08/25/2011	US20110206719 Immunostimulatory oligoribonucleotides
08/25/2011	US20110206718 Anti-fmd vaccine composition and preparation and use thereof
08/25/2011	US20110206717 Non-typhoidal salmonella vaccines
08/25/2011	US20110206716 Synergistic immunogenic fusion protein-polysaccharide conjugate
08/25/2011	US20110206715 Molecular differences between species of the m. tuberculosis complex
08/25/2011	US20110206714 Malaria vaccine compositions and constituents which elicit cell mediated immunity
08/25/2011	US20110206713 Tuberculosis vaccines comprising antigens expressed during the latent infection phase
08/25/2011	US20110206712 Tuberculosis rv2386c protein, compositions and uses thereof
08/25/2011	US20110206711 Method for inducing cytotoxic t-cells, cytotoxic t-cell inducer, and pharmaceutical composition and vaccine employing same
08/25/2011	US20110206710 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine
08/25/2011	US20110206709 T-cell antigen peptide from allergen for stimulation of il-10 production
08/25/2011	US20110206708 Method for stimulating a therapeutic immune effect in a patient
08/25/2011	US20110206707 Method for stimulating a host immune system
08/25/2011	US20110206706 Vaccine and method for treatment of neurodegenerative diseases
08/25/2011	US20110206705 B7-h3 as a biomarker for diagnosing the progression and early lymph node metastasis of cancer
08/25/2011	US20110206704 Methods and compositions for modulating hepatocyte growth factor activator
08/25/2011	US20110206703 Gene signature for predicting prognosis of patients with solid tumors
08/25/2011	US20110206702 Compositions and methods for the diagnosis and treatment of tumor
08/25/2011	US20110206701 Use of anti-cs1 antibodies for treatment of rare lymphomas
08/25/2011	US20110206700 Anti-cd33 antibodies and methods for treatment of acute myeloid leukemia using the same
08/25/2011	US20110206699 Methods for the Treatment of Graft-Versus-Host Disease
08/25/2011	US20110206698 Antagonist anti-il-7 receptor antibodies and methods
08/25/2011	US20110206697 Spink1 targeted therapy
08/25/2011	US20110206696 Methods for inhibiting bone loss and bone metastasis
08/25/2011	US20110206695 Antibodies for diagnosis and therapeutic treatment of prostate cancer
08/25/2011	US20110206694 Prevention and treatment of gram negative, flagellated bacterial infections
08/25/2011	US20110206693 Lysine riboswitch and compositions and uses thereof
08/25/2011	US20110206692 Conformers of bacterial adhesins
08/25/2011	US20110206691 Methods and Compositions for Treating Neuroblastoma
08/25/2011	US20110206690 Dimeric iap inhibitors
08/25/2011	US20110206689 Molecular Determinants Associated With Prostate Cancer And Methods Of Use Thereof
08/25/2011	US20110206688 Enhancing Vessel Lesion Homing and Repair Potential of Stem Cells
08/25/2011	US20110206687 Isolation And Purification Of Anti-IL-13 Antibodies Using Protein A Affinity Chromatography
08/25/2011	US20110206686 Il-23 antibodies
08/25/2011	US20110206685 Screening assays for inhibitors of a staphylococcus aureus siderophore
08/25/2011	US20110206684 Method of producing nutritional products from human milk tissue and compositions thereof
08/25/2011	US20110206683 Preservation mixture and use thereof
08/25/2011	US20110206682 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
08/25/2011	US20110206681 Binding molecules to the human ox40 receptor
08/25/2011	US20110206680 Methods for treating psoriasis
08/25/2011	US20110206679 New Therapeutic and Diagnostic Methods for Alzheimer's Disease
08/25/2011	US20110206678 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
08/25/2011	US20110206677 Antibodies specific for sclerostin and methods for increasing bone mineralization
08/25/2011	US20110206676 Compositions and methods related to staphylococcal bacterium proteins
08/25/2011	US20110206675 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
08/25/2011	US20110206674 Yersinia SPP. Polypeptides and Methods of Use
08/25/2011	US20110206673 Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof
08/25/2011	US20110206672 Antigen-Binding Molecule And Uses Thereof
08/25/2011	US20110206671 Axon regeneration promoter
08/25/2011	US20110206670 Methods and materials related to anti-amyloid antibodies
08/25/2011	US20110206669 Mcp1 fusions
08/25/2011	US20110206668 Methods and compositions for modulating immunity
08/25/2011	US20110206667 Polymorphism in the apo(a) gene predict responsiveness to acetylsalicylic acid treatment
08/25/2011	US20110206666 Targeting pax2 for the treatment of breast cancer
08/25/2011	US20110206665 Targeting pax2 for the treatment of breast cancer
08/25/2011	US20110206664 Therapeutic agent for chronic arthritides diseases of childhood-related diseases
08/25/2011	US20110206663 Anti-Interferon-Alpha Antibodies
08/25/2011	US20110206662 Anti-angiogenesis therapy for the treatment of ovarian cancer
08/25/2011	US20110206661 Trimethoxyphenyl inhibitors of tyrosine kinase
08/25/2011	US20110206660 Amino acid sequences directed against cxcr4 and other gpcrs and compounds comprising the same
08/25/2011	US20110206659 Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
08/25/2011	US20110206658 Compositions and methods for the treatment of tumor of hematopoietic origin
08/25/2011	US20110206657 Antibodies binding to an intracellular prl-1 or prl-3 polypeptide
08/25/2011	US20110206620 Therapeutic Compositions for the Treatment of Dry Eye Disease
08/25/2011	US20110206617 Modified polysaccharides for drug and contrast agent delivery
08/25/2011	US20110206610 Compositions and methods for enhancing drug delivery across and into epithelial tissues
08/25/2011	CA2790500A1 Epithelial membrane protein 2 (emp2) binding reagents and their therapeutic uses in ocular diseases
08/25/2011	CA2790488A1 Integrin .alpha.v.beta.8 neutrilizing antibody
08/25/2011	CA2790426A1 Vectors expressing hiv antigens and gm-csf and related methods for generating an immune response
08/25/2011	CA2790290A1 Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790289A1 Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790276A1 Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790232A1 Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790228A1 Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790203A1 Method to treat autoimmune demyelinating diseases and other autoimmune or inflammatory diseases
08/25/2011	CA2790200A1 Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and use thereof
08/25/2011	CA2789945A1 Universal virus-like particle (vlp) influenza vaccines
08/25/2011	CA2789810A1 Compositions and methods for targeting type 1 interferon producing cells

1 ... 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 ... 1823